Predicting non-response to urotherapy in pediatric bowel and bladder dysfunction: A machine learning approach

Jackson M Dunning1, Adree Khondker2, Christopher S Cooper1

  • 1Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

PubMed

Insights

Machine learning models can predict which pediatric patients with bowel and bladder dysfunction (BBD) are unlikely to respond to urotherapy alone. Identifying these non-responders early allows for timely adjustments to treatment plans, improving patient outcomes.

Area of Science:

  • Pediatric Urology
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Urotherapy is a primary treatment for pediatric bowel and bladder dysfunction (BBD).
  • A significant portion of pediatric patients exhibit limited or no response to urotherapy alone.
  • Early identification of non-responders is crucial for optimizing management and improving outcomes.

Purpose of the Study:

  • To develop and evaluate machine learning models for predicting non-response to urotherapy in pediatric BBD patients.
  • To identify key predictors of urotherapy treatment failure in children.
  • To enable earlier clinical intervention for non-responsive cases.

Main Methods:

  • Retrospective analysis of 123 pediatric patients (aged 5-10 years) with BBD.
  • Utilized a validated 18-question BBD symptomology questionnaire for data collection.
  • Developed and compared multivariable logistic regression and random Forest machine learning models to predict urotherapy non-response, evaluating performance with AUROC.

Main Results:

  • Older age and the presence of dysuria were associated with a higher likelihood of response to urotherapy.
  • Daytime incontinence at the initial visit was linked to a lower likelihood of response.
  • The random Forest model achieved a superior AUROC of 0.71 compared to logistic regression (0.67).

Conclusions:

  • Machine learning models effectively predict non-response to urotherapy in pediatric BBD.
  • Age, dysuria, and daytime incontinence are significant predictors of urotherapy outcomes.
  • Early identification of non-responders facilitates timely implementation of alternative or additional therapeutic strategies, enhancing patient care.
Abstract